Sinobiopharma Inc. (SNBP.OB) Partners with Xianfeng Pharmaceuticals to Co-produce and Market Two Biopharm Technologies
Biopharmaceutical company Sinobiopharma Inc. focuses on anesthesia-assisted agents and cardiovascular drugs. The company today announced an agreement with Anhui Xianfeng Pharmaceuticals Co. Ltd (Xianfeng) to manufacture and co-market Clindamycin and L-alanyl-L-glutamine. Clindamycin is an antibiotic used to treat anaerobic bacterial infections, some protozoal diseases (such as malaria), and is also used as a topical acne treatment cream; parenteral nutrition product L-alanyl-L-glutamine is prescribed for patients after surgery. Sinobiopharma owns the drug certificates, drug registration approval documents and production technologies of the two products. Per the agreement, Xianfeng will pay Sinobiopharma to obtain access to the technologies. Xianfeng is equipped with…